| # | Title | Journal | Year | Citations |
|---|
| 1 | New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) | European Journal of Cancer | 2009 | 21,739 |
| 2 | Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012 | European Journal of Cancer | 2013 | 4,448 |
| 3 | Radiomics: Extracting more information from medical images using advanced feature analysis | European Journal of Cancer | 2012 | 3,846 |
| 4 | A survey of telomerase activity in human cancer | European Journal of Cancer | 1997 | 2,524 |
| 5 | Estimates of cancer incidence and mortality in Europe in 2008 | European Journal of Cancer | 2010 | 1,947 |
| 6 | EGFR and cancer prognosis | European Journal of Cancer | 2001 | 1,791 |
| 7 | Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018 | European Journal of Cancer | 2018 | 1,789 |
| 8 | Cancer burden in the year 2000. The global picture | European Journal of Cancer | 2001 | 1,720 |
| 9 | Immune-related adverse events with immune checkpoint blockade: a comprehensive review | European Journal of Cancer | 2016 | 1,687 |
| 10 | Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations | European Journal of Cancer | 1999 | 1,550 |
| 11 | Cremophor EL | European Journal of Cancer | 2001 | 1,458 |
| 12 | Curcumin: The story so far | European Journal of Cancer | 2005 | 1,420 |
| 13 | The EGFR family and its ligands in human cancer | European Journal of Cancer | 2001 | 1,336 |
| 14 | The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress | European Journal of Cancer | 1994 | 1,301 |
| 15 | Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy | European Journal of Cancer | 2006 | 1,284 |
| 16 | Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue | European Journal of Cancer | 1998 | 1,143 |
| 17 | RECIST 1.1—Update and clarification: From the RECIST committee | European Journal of Cancer | 2016 | 1,143 |
| 18 | Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure | European Journal of Cancer | 2005 | 1,024 |
| 19 | Phase III trial of Anastrozole (AN) vs Tamoxifen (TAM) in Postmenopausal (PM) Patients (PTS) with hormone-dependent Advanced Breast Cancer (ABC) | European Journal of Cancer | 2001 | 973 |
| 20 | Survival in small intestinal adenocarcinoma | European Journal of Cancer | 1996 | 912 |
| 21 | 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours | European Journal of Cancer | 2011 | 895 |
| 22 | Correlation of Immunohistochemistry (IHC) and gene microarray analysis of breast biopsies from a preoperative endocrine therapy trial | European Journal of Cancer | 2001 | 836 |
| 23 | The role of IL-6 and STAT3 in inflammation and cancer | European Journal of Cancer | 2005 | 825 |
| 24 | Etoposide: four decades of development of a topoisomerase II inhibitor | European Journal of Cancer | 1998 | 818 |
| 25 | Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working group | European Journal of Cancer | 2010 | 813 |
| 26 | KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours | European Journal of Cancer | 2006 | 810 |
| 27 | The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients | European Journal of Cancer | 2004 | 749 |
| 28 | EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary | European Journal of Cancer | 2009 | 740 |
| 29 | The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials | European Journal of Cancer | 1994 | 735 |
| 30 | Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review | European Journal of Cancer | 2016 | 733 |
| 31 | Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? | European Journal of Cancer | 1998 | 700 |
| 32 | Lung cancer in never smokers – A review | European Journal of Cancer | 2012 | 694 |
| 33 | Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi | European Journal of Cancer | 2005 | 686 |
| 34 | Role of oxygen free radicals in cancer development | European Journal of Cancer | 1996 | 685 |
| 35 | Clinical development of platinum complexes in cancer therapy: an historical perspective and an update | European Journal of Cancer | 1998 | 685 |
| 36 | Correlation between immunohistochemical and fish analysis for HER-2 in 441 breast carcinomas from multiple hospitals | European Journal of Cancer | 2001 | 685 |
| 37 | A body image scale for use with cancer patients | European Journal of Cancer | 2001 | 669 |
| 38 | Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timeliness | European Journal of Cancer | 2009 | 664 |
| 39 | Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation | European Journal of Cancer | 1996 | 663 |
| 40 | NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality | European Journal of Cancer | 2012 | 661 |
| 41 | A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients | European Journal of Cancer | 2000 | 651 |
| 42 | Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s | European Journal of Cancer | 2008 | 645 |
| 43 | A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study | European Journal of Cancer | 2011 | 632 |
| 44 | Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors | European Journal of Cancer | 2005 | 622 |
| 45 | The antioxidant/anticancer potential of phenolic compounds isolated from olive oil | European Journal of Cancer | 2000 | 621 |
| 46 | Estimates of cancer incidence and mortality in Europe in 1995 | European Journal of Cancer | 2002 | 587 |
| 47 | Quality of life research within the EORTC—the EORTC QLQ-C30 | European Journal of Cancer | 2002 | 574 |
| 48 | Rare cancers are not so rare: The rare cancer burden in Europe | European Journal of Cancer | 2011 | 573 |
| 49 | Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: A systematic review and meta-analysis | European Journal of Cancer | 2009 | 572 |
| 50 | Worldwide trends in gastric cancer mortality (1980–2011), with predictions to 2015, and incidence by subtype | European Journal of Cancer | 2014 | 556 |
